Hela Apparel Holdings PLC (COSE:HELA.N0000)
Sri Lanka · Delayed Price · Currency is LKR 3.700
+0.200 (5.71%)
At close: Aug 1, 2025
CTI BioPharma Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| 83,314 | 70,289 | 95,303 | 56,180 | 32,155 | 32,874 | |
Revenue Growth (YoY) | 20.14% | -26.25% | 69.64% | 74.72% | -2.19% | - |
Cost of Revenue | 72,553 | 64,119 | 83,716 | 47,603 | 26,090 | 25,878 |
Gross Profit | 10,761 | 6,170 | 11,586 | 8,576 | 6,065 | 6,996 |
Selling, General & Admin | 17,929 | 14,351 | 12,796 | 6,681 | 4,434 | 5,162 |
Other Operating Expenses | -9,328 | -9,621 | -768.49 | -93.29 | -262.84 | -153.79 |
Operating Expenses | 8,621 | 4,750 | 12,217 | 6,586 | 4,081 | 5,008 |
Operating Income | 2,139 | 1,420 | -630.46 | 1,990 | 1,984 | 1,988 |
Interest Expense | -3,534 | -3,215 | -2,711 | -1,383 | -521.69 | -473.95 |
Interest & Investment Income | 233.24 | 112.08 | 27.91 | 46.52 | 10.17 | 10.64 |
Earnings From Equity Investments | -53.27 | -42.73 | -69.32 | -91.52 | - | - |
Currency Exchange Gain (Loss) | 262.99 | 262.99 | 996.52 | 444.68 | 84.74 | -36.69 |
Other Non Operating Income (Expenses) | -903.69 | -903.69 | -1,149 | -134.49 | -643.02 | -664.79 |
EBT Excluding Unusual Items | -1,855 | -2,367 | -3,535 | 872.14 | 914.39 | 823.63 |
Gain (Loss) on Sale of Assets | 0 | 0 | 0.44 | 0.23 | -0.95 | -11.2 |
Asset Writedown | 35.28 | 35.28 | 110.03 | -43.23 | -9.05 | 6.89 |
Other Unusual Items | - | - | - | - | 7.72 | - |
Pretax Income | -1,820 | -2,332 | -3,425 | 829.14 | 912.1 | 819.33 |
Income Tax Expense | -1,401 | -1,983 | -92.47 | 248.47 | 40.56 | 51.85 |
Earnings From Continuing Operations | -418.72 | -348.9 | -3,332 | 580.67 | 871.54 | 767.48 |
Minority Interest in Earnings | 179.31 | -24.38 | -165.87 | 3.38 | -104.69 | 37.11 |
Net Income | -239.4 | -373.28 | -3,498 | 584.04 | 766.85 | 804.59 |
Net Income to Common | -239.4 | -373.28 | -3,498 | 584.04 | 766.85 | 804.59 |
Net Income Growth | - | - | - | -23.84% | -4.69% | - |
Shares Outstanding (Basic) | 1,559 | 1,317 | 1,310 | 1,080 | 1,005 | 8 |
Shares Outstanding (Diluted) | 1,559 | 1,317 | 1,310 | 1,094 | 1,027 | 8 |
Shares Change (YoY) | 31.15% | 0.57% | 19.73% | 6.56% | 12734.45% | - |
EPS (Basic) | -0.15 | -0.28 | -2.67 | 0.54 | 0.76 | 100.57 |
EPS (Diluted) | -0.15 | -0.28 | -2.67 | 0.53 | 0.75 | 100.57 |
EPS Growth | - | - | - | -29.33% | -99.25% | - |
Free Cash Flow | -6,552 | -4,264 | 2,587 | -6,025 | 1,588 | 564.5 |
Free Cash Flow Per Share | -4.20 | -3.24 | 1.98 | -5.51 | 1.55 | 70.56 |
Gross Margin | 12.92% | 8.78% | 12.16% | 15.27% | 18.86% | 21.28% |
Operating Margin | 2.57% | 2.02% | -0.66% | 3.54% | 6.17% | 6.05% |
Profit Margin | -0.29% | -0.53% | -3.67% | 1.04% | 2.38% | 2.45% |
Free Cash Flow Margin | -7.86% | -6.07% | 2.71% | -10.72% | 4.94% | 1.72% |
EBITDA | 3,659 | 2,327 | 319.6 | 2,497 | 2,548 | 2,474 |
EBITDA Margin | 4.39% | 3.31% | 0.34% | 4.45% | 7.92% | 7.52% |
D&A For EBITDA | 1,519 | 907.68 | 950.06 | 507.22 | 563.4 | 485.25 |
EBIT | 2,139 | 1,420 | -630.46 | 1,990 | 1,984 | 1,988 |
EBIT Margin | 2.57% | 2.02% | -0.66% | 3.54% | 6.17% | 6.05% |
Effective Tax Rate | - | - | - | 29.97% | 4.45% | 6.33% |
Updated Feb 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.